Key Details
Price
$1.59Annual ROE
1531.23%Beta
0.14Events Calendar
Next earnings date:
May 14, 2025Recent quarterly earnings:
Feb 13, 2025Recent annual earnings:
Dec 17, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Sep 30, 2024Analyst ratings
Recent major analysts updates
Dec 20, 24 Chardan Capital
BuyAug 23, 24 Chardan Capital
BuyMay 28, 24 Chardan Capital
BuyMay 16, 24 EF Hutton
BuyFeb 15, 24 Chardan Capital
BuyNov 27, 23 Ladenburg Thalmann
BuyAug 16, 23 Chardan Capital
BuyJun 26, 23 EF Hutton
BuyMay 11, 23 Chardan Capital
BuyApr 19, 23 EF Hutton
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Sonnet BioTherapeutics Holdings doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Sonnet BioTherapeutics Holdings?
- Does Sonnet BioTherapeutics Holdings pay dividends?
- What sector is Sonnet BioTherapeutics Holdings in?
- What industry is Sonnet BioTherapeutics Holdings in?
- What country is Sonnet BioTherapeutics Holdings based in?
- When did Sonnet BioTherapeutics Holdings go public?
- Is Sonnet BioTherapeutics Holdings in the S&P 500?
- Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?
- Is Sonnet BioTherapeutics Holdings in the Dow Jones?
- When was Sonnet BioTherapeutics Holdings's last earnings report?
- When does Sonnet BioTherapeutics Holdings report earnings?
- Should I buy Sonnet BioTherapeutics Holdings stock now?
What is the ticker symbol for Sonnet BioTherapeutics Holdings?
The ticker symbol for Sonnet BioTherapeutics Holdings is NASDAQ:SONN
Does Sonnet BioTherapeutics Holdings pay dividends?
No, Sonnet BioTherapeutics Holdings does not pay dividends
What sector is Sonnet BioTherapeutics Holdings in?
Sonnet BioTherapeutics Holdings is in the Healthcare sector
What industry is Sonnet BioTherapeutics Holdings in?
Sonnet BioTherapeutics Holdings is in the Biotechnology industry
What country is Sonnet BioTherapeutics Holdings based in?
Sonnet BioTherapeutics Holdings is headquartered in United States
When did Sonnet BioTherapeutics Holdings go public?
Sonnet BioTherapeutics Holdings's initial public offering (IPO) was on October 31, 2006
Is Sonnet BioTherapeutics Holdings in the S&P 500?
No, Sonnet BioTherapeutics Holdings is not included in the S&P 500 index
Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?
No, Sonnet BioTherapeutics Holdings is not included in the NASDAQ 100 index
Is Sonnet BioTherapeutics Holdings in the Dow Jones?
No, Sonnet BioTherapeutics Holdings is not included in the Dow Jones index
When was Sonnet BioTherapeutics Holdings's last earnings report?
Sonnet BioTherapeutics Holdings's most recent earnings report was on Feb 13, 2025
When does Sonnet BioTherapeutics Holdings report earnings?
The next expected earnings date for Sonnet BioTherapeutics Holdings is May 14, 2025
Should I buy Sonnet BioTherapeutics Holdings stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions